Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

13.23
BATS BZX Real-Time Price
As of 3:43pm ET
 -0.035 / -0.26%
Today’s Change
10.85
Today|||52-Week Range
18.48
-6.54%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.4B

Company Description

Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. It develops Zerenex, an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes. The company was founded in October 1998 and is headquartered in New York, NY.

Contact Information

Keryx Biopharmaceuticals, Inc.
750 Lexington Avenue
New York New York 10022
P:(212) 531-5965
Investor Relations:
(212) 531-5962

Employees

Shareholders

Other institutional42.20%
Mutual fund holders37.61%
Individual stakeholders14.71%

Top Executives

Ronald BentsurChief Executive Officer & Director
Gregory P. MadisonPresident, Chief Operating Officer & Executive VP
James F. OlivieroCFO, Secretary, Treasurer & CAO
Amit SharmaVice President-Medical Affairs
Douglass H. LaidlawDirector-Medical Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account